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Over the past decade, we have learned much about the 
problems associated with acute brain dysfunction during 
critical illness; currently, awareness of the ubiquitous 
presence of intensive care unit (ICU) delirium is growing. 
Th  e paper by Pandharipande and colleagues [1] in the 
previous issue of Critical Care adds insight into this 
complex area. In 2004, Ely and colleagues [2] published 
groundbreaking work that identiﬁ  ed ICU delirium as an 
event occurring in over 80% of mechanically ventilated 
patients; those with ICU delirium had a threefold higher 
independent mortality risk compared with those who 
never had ICU delirium. Over the last 10 years, this 
group of investigators has worked extensively in the 
development and validation of the confusion assessment 
method for the ICU (CAM-ICU) to detect and better 
understand ICU delirium. According to this tool, 
delirium is deﬁ  ned as an acute change or ﬂ  uctuation in 
the course of mental status, plus inattention and either 
disorganized thinking or an altered level of consciousness 
[3]. Th  e CAM-ICU tool uses the Richmond Agitation-
Sedation Scale (RASS) to measure arousal [4]. Patients 
who are deeply unresponsive are categorized as comatose 
rather than delirious; that is, they respond only to 
physical/painful stimulation by moving but do not open 
their eyes (RASS score of −4) or have no response to 
verbal or physical stimulation (RASS score of −5). 
Patients who are neither delirious nor  comatose are 
categorized as normal. Although coma and delirium are 
diﬀ  erent conditions, both can be placed in a category of 
acute brain dysfunction.
Delirium (like acute brain dysfunction, for that matter) 
is not a disease but a syndrome with a wide spectrum of 
possible etiologies. Over the last few years, we have 
learned that ICU delirium does not come as a ‘one size 
ﬁ  ts all’ event. Rather, it appears that the longer [5] and 
more severe [6] the delirium is, the worse the patient 
outcomes are.
As reported in the previous issue of Critical Care, 
Pandharipande and colleagues [1] use data from the 
MENDS (maximizing eﬃ   cacy of targeted sedation and 
reducing neurological dysfunction) trial, which compared 
dexmedetomidine with lorazepam for ICU sedation in a 
randomized double-blinded fashion [7]. Sixty-one 
percent of patients (61/103) in the MENDS trial were 
admitted with sepsis. In this important post hoc analysis 
of these septic patients, dexmedetomidine-sedated 
patients had more delirium/coma-free days, delirium-
free days, and ventilator-free days and a lower 28-day 
mortality rate when compared with lorazepam-sedated 
patients [1]. It is important to realize that the randomi-
zation scheme for the MENDS trial was to dexmedeto-
midine versus lorazepam, not septic versus non-septic. 
Accordingly, the authors conclude (appropriately) that 
prospective clinical studies and further mechanistic 
preclinical studies are needed to conﬁ  rm  these 
preliminary obser  vational results.
Acute brain dysfunction is common in patients with 
sepsis. Th   e mechanisms by which such brain dysfunction 
occurs are not fully understood, but disturbances in 
inﬂ   ammation and coagulation pathways leading to 
micro  vascular thrombosis are thought to be partly res-
ponsible. Th  e commonplace administration of seda  tives 
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additional layer of complexity to understanding acute 
brain dysfunction in these patients. As noted by 
Pandharipande and colleagues [1], there is some evidence 
that benzodiazepines and alpha-2 adrenoceptor agonists 
exert opposing eﬀ   ects on the immune system. So it 
stands to reason that dexmedetomidine may be more 
eﬃ     cacious than lorazepam with regard to acute brain 
dysfunction in patients with sepsis.
As is the case in most well-designed trials, these results 
produce as many questions as they do answers. For 
example, in septic patients, how does one tease apart the 
impact of dexmedetomidine (compared with lorazepam) 
on sedation itself from the putative beneﬁ  ts of dex  mede-
tomidine on immune modulation, apoptosis, and so on?
How does the timing of the CAM-ICU delirium 
assessment impact the ﬁ  ndings in this study? Given the 
pharmacokinetic/dynamic properties of dexmedetomi-
dine and lorazepam, whatever component of recovery 
from delirium or coma (or both) that is purely sedative-
related is likely to occur over diﬀ   ering time intervals 
when these two drugs are compared (that is, slower 
recovery and longer delirium/coma with lorazepam). 
Since the multicenter MENDS trial did not mandate one 
particular sedation algorithm, it may be that lingering 
eﬀ  ects of lorazepam may have aﬀ  ected the CAM-ICU 
delirium or coma assessments (or both) more in the 
dexmedetomidine group.
Th  e distinction between delirium and coma in the 
CAM-ICU tool is logical but arbitrary. As a person 
transitions from a RASS score of −3 (opens the eyes or 
moves in response to voice but does not make eye 
contact) to −4 (responds only to physical/painful stimu-
lation by moving but does not open the eyes), the term 
coma, rather than delirium, is used. With regard to acute 
brain dysfunction, is the delirium-to-coma transition 
merely a continuum of progressively lesser degrees of 
arousal, or is there a fundamental change in the patho-
physiology of the acute brain dysfunction with this transi-
tion? Th   ese questions remain unanswered at present.
Th  e paper by Pandharipande and colleagues is an 
important advance in our understanding of the complex 
interconnections between acute brain dysfunction, 
sedation, and sepsis. However, we need further progress 
in our understanding of the complex pathophysiology of 
acute brain dysfunction in critically ill patients who 
require mechanical ventilation. Th  is  hypothesis-generat-
ing study lays important groundwork for future investi-
gations of sepsis and sedation in this area.
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